Chromosome Y News and Research

RSS
The Y chromosome is one of the two sex chromosomes in humans (the other is the X chromosome). The sex chromosomes form one of the 23 pairs of human chromosomes in each cell. The Y chromosome spans about 58 million base pairs (the building blocks of DNA) and represents almost 2 percent of the total DNA in cells.

Each person normally has one pair of sex chromosomes in each cell. The Y chromosome is present in males, who have one X and one Y chromosome, while females have two X chromosomes.

Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. The Y chromosome likely contains between 70 and 200 genes. Because only males have the Y chromosome, the genes on this chromosome tend to be involved in male sex determination and development. Sex is determined by the SRY gene, which is responsible for the development of a fetus into a male. Other genes on the Y chromosome are important for male fertility.

Many genes are unique to the X or Y chromosome, but genes in an area known as the pseudoautosomal region are present on both chromosomes. As a result, men and women each have two functional copies of these genes. Many genes in the pseudoautosomal region are essential for normal development.

Genes on the Y chromosome are among the estimated 20,000 to 25,000 total genes in the human genome.
Landmark study provides new insight into congenital heart defects

Landmark study provides new insight into congenital heart defects

Genes work together by huddling in clusters inside nucleus, research reveals

Genes work together by huddling in clusters inside nucleus, research reveals

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

Study may help in treating sex differentiation disorders in children

Study may help in treating sex differentiation disorders in children

Researchers discover new explanation for differences in severity of mental illness in males

Researchers discover new explanation for differences in severity of mental illness in males

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Enzo Biochem and Ikonisys sign agreement to market molecular-based cervical cancer test

Enzo Biochem and Ikonisys sign agreement to market molecular-based cervical cancer test

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Positive data from ARIAD Pharmaceuticals' ongoing AP24534 study in advanced hematological cancer patients

Positive data from ARIAD Pharmaceuticals' ongoing AP24534 study in advanced hematological cancer patients

New genetic approach may hold promise for sickle cell disease

New genetic approach may hold promise for sickle cell disease

Animal study demonstrates how whole chromosome changes cause cancer

Animal study demonstrates how whole chromosome changes cause cancer

Phase II clinical trial results reveal positive effects of omacetaxine against CML

Phase II clinical trial results reveal positive effects of omacetaxine against CML

New findings may yield more effective therapies for infants with blood cancer

New findings may yield more effective therapies for infants with blood cancer

New study reveals genetic alteration can lead to severe childhood obesity

New study reveals genetic alteration can lead to severe childhood obesity

New treatment options for leukemia and myeloproliferative disorders introduced

New treatment options for leukemia and myeloproliferative disorders introduced

IMF to stage presentation on multiple myeloma at ASH annual meeting

IMF to stage presentation on multiple myeloma at ASH annual meeting

Researchers discover mechanism that explains how chromosomal translocations are not random

Researchers discover mechanism that explains how chromosomal translocations are not random

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.